Evolution of tigecycline- and colistin-resistant CRKP (carbapenem-resistant Klebsiella pneumoniae) in vivo and its persistence in the GI tract article

Emerging Microbes and Infections

Volumn 7, Issue 1, 2018, Pages

  Zhang, Rong ^a   Dong, Ning ^b   Huang, Yonglu ^a   Zhou, Hongwei ^a   Xie, Miaomiao ^b   Chan, Edward Wai Chi ^b   Hu, Yanyan ^a   Cai, Jiachang ^a   Chen, Sheng ^b  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; COLISTIN; FOSFOMYCIN; ISEPAMICIN; MEROPENEM; PIPERACILLIN; POLYMYXIN B; TIGECYCLINE; VANCOMYCIN; VORICONAZOLE; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CARBAPENEM DERIVATIVE; CASPOFUNGIN; ECHINOCANDIN; LIPOPEPTIDE; MINOCYCLINE;

ACUTE MONOCYTIC LEUKEMIA; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BLA KPC 2 GENE; CANCER CHEMOTHERAPY; CASE REPORT; CHINA; CLINICAL ARTICLE; COLISTIN RESISTANT KLEBSIELLA PNEUMONIAE; CONJUGATIVE PLASMID; DIARRHEA; DRUG MEGADOSE; ESCHERICHIA COLI; FEVER; GASTROINTESTINAL TRACT; GENE; GENE EXPRESSION; GENETIC DIFFERENCE; GENETIC SCREENING; GENETIC VARIABILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL READMISSION; HUMAN; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LUNG INFECTION; MALE; MCR 1 GENE; MGRB GENE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROPHYLAXIS; SOUTHERN BLOTTING; TENESMUS; TET(A) GENE; TIGECYCLINE RESISTANT KLEBSIELLA PNEUMONIAE; WHOLE GENOME SEQUENCING; ANALOGS AND DERIVATIVES; ANTIBIOTIC RESISTANCE; DRUG EFFECT; FECES; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADULT; ANTIFUNGAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBAPENEMS; COLISTIN; DIARRHEA; DRUG RESISTANCE, BACTERIAL; ECHINOCANDINS; FECES; GASTROINTESTINAL TRACT; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LEUKEMIA, MONOCYTIC, ACUTE; LIPOPEPTIDES; MALE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; TREATMENT OUTCOME;

EID: 85049744272     PISSN: None     EISSN: 22221751     Source Type: Journal    
DOI: 10.1038/s41426-018-0129-7     Document Type: Article

References (33)

1. Martinez-Martinez, L. &Gonzalez-Lopez, J. J. Carbapenemases in Enterobacteriaceae: types and molecular epidemiology. Enferm. Infecc. Microbiol. Clin. 32(Suppl. 4), 4-9, https://doi.org/10.1016/S0213-005X(14)70168-5 (2014).
2. Landman, D., Georgescu, C., Martin, D. A. &Quale, J. Polymyxins revisited. Clin. Microbiol. Rev. 21, 449-465, https://doi.org/10.1128/CMR.00006-08 (2008).
3. Yuan, Z. &Tam, V. H. Polymyxin B: a new strategy for multidrug-resistant Gram-negative organisms. Expert. Opin. Investig. Drugs 17, 661-668, https://doi. org/10.1517/13543784.17.5.661 (2008).
4. Liu, Y. Y. et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 16, 161-168, https://doi.org/10.1016/ S1473-3099(15)00424-7 (2016).
5. Cunha, C. B. et al. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors. Am. J. Infect. Control 44, 126-130, https://doi.org/ 10.1016/j.ajic.2015.09.019 (2016).
6. Torres-Gonzalez, P. et al. Factors associated to prevalence and incidence of carbapenem-resistant enterobacteriaceae fecal carriage: a cohort study in a Mexican Tertiary Care Hospital. PLoS One 10, e0139883, https://doi.org/ 10.1371/journal.pone.0139883 (2015).
7. Zhao, Z. C. et al. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university 395 hospita. Am J Infect Control 42, e61-e64, https://doi. org/10.1016/j.ajic.2014.01.024 (2014).
8. Hu, Y., Liu, F., Lin, I. Y., Gao, G. F. &Zhu, B. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect. Dis. 16, 146-147, https://doi.org/10.1016/S1473-3099(15)00533-2 (2016).
9. Yao, H., Qin, S., Chen, S., Shen, J. &Du, X. D. Emergence of carbapenemresistant hypervirulent Klebsiella pneumoniae. Lancet Infect. Dis. 18, 25, https:// doi.org/10.1016/S1473-3099(17)30628-X (2018).
10. Poirel, L. et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J. Antimicrob. Chemother. 70, 75-80, https://doi.org/ 10.1093/jac/dku323 (2015).
11. Gu, D. et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect. Dis. 18, 37-46, https://doi.org/10.1016/S1473-3099(17) 30489-9 (2018).
12. Abdallah, H. M. et al. Fecal carriage of extended-spectrum beta-lactamase-and carbapenemase-producing Enterobacteriaceae in Egyptian patients with community-onset gastrointestinal complaints: a hospital-based crosssectional study. Antimicrob. Resist. Infect. Control 6, 62, https://doi.org/ 10.1186/s13756-017-0219-7 (2017).
13. Zaidah, A. R., Mohammad, N. I., Suraiya, S. &Harun, A. High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting. Antimicrob. Resist. Infect. Control 6, 42, https://doi.org/10.1186/s13756-017-0200-5 (2017).
14. Nabarro, L. E. &Veeraraghavan, B. Combination therapy for carbapenemresistant Enterobacteriaceae: increasing evidence, unanswered questions, potential solutions. Eur. J. Clin. Microbiol. Infect. Dis. 34, 2307-2311, https://doi. org/10.1007/s10096-015-2486-7 (2015).
15. van Duin, D., Kaye, K. S., Neuner, E. A. &Bonomo, R. A. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn. Microbiol. Infect. Dis. 75, 115-120, https://doi.org/10.1016/j.diagmicrobio.2012.11.009 (2013).
16. Quan, J. et al. Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study. Lancet Infect. Dis. 17, 400-410, https://doi.org/10.1016/ S1473-3099(16)30528-X (2017).
17. Du, H., Chen, L., Tang, Y. W. &Kreiswirth, B. N. Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae. Lancet Infect. Dis. 16, 287-288, https://doi.org/10.1016/S1473-3099(16)00056-6 (2016).
18. Yang, R. S. et al. Emergence of NDM-5-and MCR-1-producing Escherichia coli clones ST648 and ST156 from a Single Muscovy Duck (Cairina moschata). Antimicrob. Agents Chemother. 60, 6899-6902, https://doi.org/10.1128/ AAC.01365-16 (2016).
19. Yao, X., Doi, Y., Zeng, L., Lv, L. &Liu, J. H. Carbapenem-resistant and colistinresistant Escherichia coli co-producing NDM-9 and MCR-1. Lancet Infect. Dis. 16, 288-289, https://doi.org/10.1016/S1473-3099(16)00057-8 (2016).
20. Zheng, B. et al. Coexistence of MCR-1 and NDM-1 in clinical Escherichia coli isolates. Clin. Infect. Dis. 63, 1393-1395, https://doi.org/10.1093/cid/ciw553 (2016).
21. Mawal, Y., Critchley, I. A., Riccobene, T. A., &Talley, A. K. Ceftazidime-avibactam for the treatment 434 of complicated urinary tract infections and complicated intra-abdominal infections. Exp. Rev. Clin. Pharmacol. 8, 691-707, https://doi. org/10.1586/17512433.2015.1090874 (2015).
22. Torres, A. et al. Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial. Lancet Infect. Dis. 18, 285-295, https://doi.org/10.1016/S1473-3099(17)30747-8 (2018).
23. Chen, K. et al. Widespread distribution of mcr-1-bearing bacteria in the ecosystem, 2015 to 2016. Euro Surveill. e39, https://doi.org/10.2807/1560-7917. ES.2017.22.39.17-00206 (2017).
24. Wang, X. et al. Increased prevalence of carbapenem resistant Enterobacteriaceae in hospital setting due 442 to cross-species transmission of the bla NDM-1 element and clonal spread of progenitor resistant 443 strains. Front Microbiol 6, 595, https://doi.org/10.3389/fmicb.2015.00595 (2015).
25. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. Twenty-third informational supplement. CLSI document M100-S26 (Clinical and Laboratory Standards Institute, Wayne, PA, 2016).
26. Dallenne, C., Da Costa, A., Decre, D., Favier, C. &Arlet, G. Development of a set of multiplex PCR assays for the detection of genes encoding important betalactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 65, 490-495, https://doi.org/10.1093/jac/dkp498 (2010).
27. Ribot, E. M. et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of 452 Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 3, 59-67, https://doi.org/10.1089/fpd.2006.3.59 (2016).
28. Antipov, D., Korobeynikov, A., McLean, J. S. &Pevzner, P. A. hybrid-SPAdes: an algorithm for hybrid assembly of short and long reads. Bioinformatics 32, 1009-1015, https://doi.org/10.1093/bioinformatics/ btv688 (2016).
29. Overbeek, R. et al. The SEED and the rapid annotation of microbial genomes using subsystems technology (RAST). Nucleic Acids Res. 42, D206-D214, https://doi.org/10.1093/nar/gkt1226 (2014).
30. Seemann, T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30, 2068-2069, https://doi.org/10.1093/bioinformatics/btu153 (2014).
31. Nabil-Fareed Alikhan, N. K. P., Nouri, L. BenZakour &Scott, A. Beatson. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genom. 12, 402 (2011).
32. Page, A. J. et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics 31, 3691-3693, https://doi.org/10.1093/bioinformatics/btv421 (2015).
33. Wyres, K. L. et al. Identification of Klebsiella capsule synthesis loci from whole genome data. Microb. Genom. 2, e000102, https://doi.org/10.1099/ mgen.0.000102 (2016).